Home Industry Reports Custom Research Blogs About Us Contact us

Newborn Screening Market Analysis

Report ID: FBI 4145

|

Published Date: Jun-2024

|

Format : PDF, Excel

Segmentation Analysis:

""

In terms of segmentation, the global newborn screening market is analyzed on the basis of Product Type, Technology, Test Type, End-Use.

Segment Analysis on Newborn Screening Market:

Product Type:

The Newborn Screening market is segmented into Instruments and Consumables. Instruments segment is expected to dominate the market due to the rising demand for advanced screening technologies and equipment in healthcare facilities. Consumables segment is also anticipated to witness significant growth owing to the increasing adoption of screening tests by laboratories and clinics.

Technology:

The Newborn Screening market is divided into Tandem Mass Spectrometry, Oximetry, Enzyme-Based Assays, and DNA Assays. Tandem Mass Spectrometry technology is projected to hold a substantial market share due to its high accuracy and efficiency in detecting metabolic disorders in newborns. Oximetry technology is also expected to grow significantly with the rise in the prevalence of congenital heart diseases among infants.

Test Type:

The Test Type segment includes Dried Blood Spot, Hearing Screening, and CCHD. Dried Blood Spot test is anticipated to lead the market as it is a cost-effective and non-invasive method for screening various disorders in newborns. Hearing Screening test is also likely to witness growth due to the increasing awareness about early detection of hearing impairments in infants.

End-use:

The End-use segment comprises Hospitals, Diagnostic Centers, and Research Laboratories. Hospitals are expected to be the major end-users of newborn screening services as they cater to a large number of newborns and have the required infrastructure for conducting screening tests. Diagnostic Centers and Research Laboratories are also projected to contribute significantly to the market growth with their increasing focus on early diagnosis and treatment of genetic disorders in newborns.

Get more details on this report -

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Newborn Screening Market Size & Share, By Product ...

RD Code : 24